FOXO TECHNOLOGIES INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- FOXO TECHNOLOGIES INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $3.00M.
- FOXO TECHNOLOGIES INC. stock issued during period, value, new issues for the quarter ending 2022-12-31 was $0.00.
- FOXO TECHNOLOGIES INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $6.67M.
- FOXO TECHNOLOGIES INC. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $89.00K.
- FOXO TECHNOLOGIES INC. stock issued during period, value, new issues for fiscal 2022 was $6.90M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-06-30 | $3.00M 10-Q · filed 2025-11-10 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $6.90M 10-K · filed 2023-03-31 |
| 2022-09-30 | $6.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | |
| 2022-06-30 | $89.00K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |